{"disease":{"id":"neuroendocrine-tumours","name":"neuroendocrine tumours"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02923934","title":"A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Olivia Newton-John Cancer Research Institute","has_results":false},{"nct_id":"NCT03592940","title":"The Management of Neuroendocrine Tumours: A Nutritional Viewpoint.","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT02651987","title":"Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Ipsen","has_results":true},{"nct_id":"NCT00323076","title":"[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":92,"lead_sponsor_name":"AHS Cancer Control Alberta","has_results":false},{"nct_id":"NCT04649580","title":"United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT04579679","title":"Open-Label Surufatinib in European Patients With NET","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":78,"lead_sponsor_name":"Hutchmed","has_results":true},{"nct_id":"NCT07077564","title":"The Efficacy of TROP2-ADC in Advanced Extrapulmonary High-Grade Neuroendocrine Neoplasms Failure of Standard Therapy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07279532","title":"Clinical Study of Adjuvant Surufatinib Therapy for Postoperative High-risk Neuroendocrine Tumors Based on the Ninth Edition of the AJCC Staging System","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04525638","title":"A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Fundación de investigación HM","has_results":false},{"nct_id":"NCT07404176","title":"Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Tata Memorial Hospital","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}